The Abiomed Inc. (ABMD) shares are trading at lower $239.27 and the avg recommendation for the stock is Moderate Buy. The current analyst price target stands at $214.40.
To add more color to this target, the company’s high over the last year is $285.77 and the low is $119.01. Over the last 52 weeks, ABMD is down -16.27% while the S&P 500 is down -2.38%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, ABMD reported a profit of $167.29 million. Abiomed Inc. also saw revenues increase to $206.66 million. In addition, ABMD has free cash flow of $270.91 million as of 03-2020 The company’s EBITDA came in at $64.06 million which compares well with its peers.
ABMD booked profit margins of 24.10%, its Return on Equity (ROE) is 19.80%, and its Return on Assets is 17.40%. All told, it is clear that, ABMD needs to be on your watchlist.
Find out when ABMD reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ABMD has a short ratio of 4.25 and outstanding shares of 45.04M.
ABMD has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.47 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 4.43. Abiomed Inc. ABMD also noted assets of $1.22 billion at the end of the last quarter. Investors should also keep an eye on sector updates as ABMD has historically followed its peers on positive news.
All told, Abiomed Inc. ABMD has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ABMD represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Abiomed Inc. ABMD is now commanding a market cap of 10.87B and a float of 44.07M. ABMD is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ABMD stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in ABMD, either long or short, and we have not been compensated for this article.